Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Uterine Cervical Neoplasms × Nivolumab × Clear all

Phase

Phase 2 7 Phase 1/2 5 Phase 1 4 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Carcinoma 1 Neoplasms 1 Malignant Ascites 1 Lung Neoplasms 1 Glioma 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Colposcopy 16 Methods 11 Cisplatin 10 Human Papillomavirus DNA Tests 9 Early Intervention, Educational 9 Brachytherapy 8 Papanicolaou Test 7 Magnetic Resonance Spectroscopy 7 Educational Status 7 Blood Specimen Collection 7 Biopsy 7 Vaginal Smears 6 Radiotherapy 6 Surveys and Questionnaires 5 Standard of Care 5 Patient Navigation 5 Therapeutics 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Mass Screening 4 Counseling 4 Sentinel Lymph Node Biopsy 3 Psychiatric Rehabilitation 3 Palliative Care 3 Paclitaxel 3 Drug Therapy 3 Diet Therapy 3 Conization 3 Acetic Acid 3 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04256213 2024-12-12

COLIBRI

ARCAGY/ GINECO GROUP

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡